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ABSTRACT
Background Using data from general adult population, this study aims to describe epidemiology of alcohol consumption patterns and their
association with cardiovascular risk.
Methods CESCAS I is a population-based study from four mid-sized cities in Argentina, Chile and Uruguay. Associations between diabetes,
hypertension, dyslipidemia, cardiovascular disease (CVD) risk and history of CVD and drinking patterns were assessed using crude prevalence
odds ratios (ORs) and adjusted OR.
Results A total of 37.2% of the studied population never drank and 18.3% reported to be former drinkers. Among current drinkers, moderate
drinking was the most frequent pattern (24.2%). For women with light and moderate consumption, the odds of having >20% CVD risk was
~40% lower than that of never drinkers. The odds of having a history of CVD was 50% lower in those with moderate consumption. For men
with heavy consumption, the odds of having >20% CVD risk was about twice as high as for never drinkers.
Conclusions A harmful association was observed between heavy drinking and having >20% CVD risk for men. However, for women, an
apparently protective association was observed between light and moderate drinking and having >20% CVD risk and between moderate
drinking and having a history of CVD.
Keywords alcohol consumption, circulatory disease, epidemiology
Introduction
In 2012, it was estimated that 5.9% of total deaths and a bur-
den of 5.1 years of life adjusted for disability (DALYs) were
attributed to alcohol consumption worldwide.1 The 2016 edi-
tion of Institute for Health Metrics and Evaluation (IHME)
global burden of disease study (GBD), estimated that a sig-
nificant toll of ~335 000 deaths globally were caused by cir-
rhosis and other chronic liver diseases due to alcohol use
and ~174 000 deaths were from alcohol use disorders.2
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In Argentina, Chile and Uruguay alcohol per capita con-
sumption is among the highest in Latin America.3 Only in
Argentina there are 2.3 million new consumers yearly.4 High
alcohol consumption has been clearly associated with acci-
dents, different types of cancers, liver cirrhosis, hemorrhagic
stroke, alcoholic cardiomyopathy and other conditions.5
However, moderate alcohol consumption has been suggested
to be associated with protective effects for some conditions,
depicting a possible J-shaped relationship for cardiovascular
disease (CVD),6–11 diabetes mellitus and all-cause mortal-
ity.3,7 In fact, the effect of alcohol and CVD appears to be
complex and mediated through various pathophysiological
mechanisms. Although some studies state that light to mod-
erate alcohol consumption could be associated with lower
risk of coronary heart disease and total mortality ischemic
heart disease,12,13 high alcohol consumption has also been
related to hypertensive disease14 arrhythmias15 and stroke.16
Moreover, quantification of effects on CVD is also com-
plex. Our group estimated that the cardio-protective effect of
regular and moderate alcohol drinking on CVD slightly out-
weighed the harmful impact of binge drinking on CVD in
2010.17 Drinking volume, frequency and patterns are import-
ant to establish risk, since binge drinking for example, has
been shown to increase alcohol-attributable mortality.18–20
World Health Organization (WHO) published the Global
Status Report on Alcohol with data from several countries in an
effort to generate comparable data across different countries21;
however, there is very little research on alcohol consumption
and its deleterious effects from a public health perspective in the
Southern Cone of Latin America. It is largely unknown what the
drinking patterns are in this region, or the degree of exposure of
the population to different volumes. National surveys in
Argentina and Uruguay shed some light showing that half of the
population reported having consumed alcohol in the last 30
days, being that prevalence higher in men than in women in
both countries.22,23 The objective of this article is to describe the
epidemiology of alcohol consumption patterns and their associ-
ation with cardiovascular risk the in the general adult population
of four cities in the Southern Cone of Latin America.
Methods
Study participants
The CESCAS (Centro de Excelencia en Salud
Cardiovascular para el Cono Sur) I study is a population-
based study with multistage probabilistic sampling in general
population from four representative cities in the Southern
Cone of Latin America, aimed to examine CVD and risk
factors. CESCAS I design and sampling method have been
published elsewhere.24,25 Briefly, 7524 women and men,
aged 35 to 74 years old, were recruited between February
2010 and December 2011 from population-representative
samples of four small to mid-sized cities in the Southern
Cone of Latin America: two in Argentina (Bariloche and
Marcos Paz), one in Chile (Temuco) and one in Uruguay
(Canelones-Barros Blancos). These study locations were
selected based on population characteristics reflecting coun-
try averages. The overall response rate was 73.4%, and these
rates were similar in men and women and across different
locations.
The study complies with the Declaration of Helsinki. The
study protocol has been approved by Institutional Review
Boards (IRBs) for all participating institutions in Argentina,
Chile, Uruguay and USA. The written informed consent has
been obtained from all study participants.
Data collection
Study data were collected at a home visit and a clinical visit
by trained staff. During the home survey, information was
obtained on demographic characteristics, including age, sex,
education and occupation. Alcohol consumption data were
collected through a structured questionnaire (appendix) based
on the Hispanic Community Health Study/Study of Latinos
cross-culturally adapted for use in Argentina, Chile and
Uruguay.24,26 Anthropometric measurements were obtained
by trained and certified observers using standard protocols
and techniques. Three blood pressure (BP) measurements
were obtained with the participant in the seated position after
5 min of rest using a standard mercury or aneroid sphygmo-
manometer, and the mean of three readings was used for
analysis. Body weight, height and waist circumference were
measured twice during the examination and the average of
two measurements was used in all analyses. Weight was mea-
sured in light indoor clothing without shoes in kilograms to
one decimal place, using standing scales. Height was mea-
sured without shoes in centimeters to one decimal place using
a wall-mounted stadiometer. Waist circumference was mea-
sured at 1 cm above the navel at minimal respiration, in centi-
meters to one decimal place.
Overnight fasting blood specimens were obtained for meas-
urement of lipids, creatinine and glucose. The duration of fast-
ing was verified before the blood specimen was obtained.
Participants who had not fasted for at least 10 hours did not
have their blood drawn. Blood glucose, total and High Density
Lipoprotein (HDL) cholesterol and triglycerides were measured
using standard methods. Concentration of Low Density
Lipoprotein (LDL) cholesterol was calculated using the
Friedewald equation for participants who had <400mg/dl
triglycerides.27
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Definitions
Obesity was defined as body mass index (BMI) ≥ 30 kg/m2
and overweight as BMI ≥ 25 and <30 kg/m2. Hypertension
was defined as mean systolic BP ≥140 mmHg and/or mean
diastolic BP ≥90 mmHg and/or current use of antihyperten-
sive medications. Dyslipidemia was defined as total cholesterol
≥240 mg/dl and/or LDL-cholesterol ≥160 mg/dl and/or
HDL-cholesterol <40 mg/dl and/or triglyceride ≥200 mg/dl
and/or use of lipid-lowering medication. Diabetes was defined
as fasting glucose ≥126 mg/dl and/or self-reported history of
diabetes and/or current use of insulin or antidiabetic medica-
tions. History of CVD was registered by self-report and
included self-reported history of heart attack, angina, revascu-
larization, stroke/transient ischemic attack or heart failure.
CVD risk was estimated using the Framingham Risk Score.28
Low CVD risk was defined as a ≤10% 10-years risk, moder-
ate as 10–20% and high risk as >20% 10-year-risk.
Patterns of alcohol consumption were classified according
to Drinking Levels Defined as published by the National
Institute of Alcohol Abuse and Alcoholism29 as the follow-
ing mutually exclusive categories: never drinker, former drin-
kers (stopped drinking one or more years ago), moderate
(up to seven drinks per week for women and up to 14
drinks per week for men); heavy drinker (eight or more
drinks per week for women and 15 or more drinks per week
for men) and binge drinker (any person that reported four
drinks for women and five drinks for men, in ~2 hours
more than once a month). Depending of average volume
per day of drinking alcohol, participants were classified using
the following classification published by WHO30: abstainers
(never and former drinkers), drinker I (females 0–19.99 gr
pure alcohol daily, males 0–39.99 g pure alcohol), drinker II
(females 20–39.99 g pure alcohol, males 40–59.99 g pure
alcohol) and drinker III (females ≥40 g pure alcohol, males
≥60 g pure alcohol). Among drinkers, types of beverages
were categorized as wine, beer and spirits based on con-
sumption during last week. For drinkers who had not drunk
during the previous week, the type of beverage was con-
sidered as undefined.
Statistical analysis
All estimates were weighed to represent the general adult
population aged 35–74 years in the study sites, according to
the study sampling design. Estimates of prevalence were
reported as proportions with 95% confidential intervals (CI).
Standard errors were calculated by means of an appropriate
technique for a complex survey design.24,31 To evaluate the
validity of self-reported alcohol intake, one-way ANOVA
with linear polynomial contrast was performed between
HDL-c levels and categories of average volume per day of
drinking alcohol. Gender-stratified analyses were performed
to explore behavioral differences between men and women.
The association of diabetes, hypertension, dyslipidemia, car-
diovascular risk and history of CVD with drinking patterns
was assessed using crude prevalence odds ratios (ORs) and
adjusted OR which were adjusted for age, education, city,
hypertension, diabetes and current smoking. All data ana-
lyses were conducted using SAS 9.3 (SAS Institute, Cary
NC).
Results
Demographic and risk factors
Table 1 shows CESCAS participants baseline characteristics.
In general, 29.7% of the CESCAS population reported to
currently smoke cigarettes, 40.8% had hypertension, 12.4%
had diabetes, 24.4% had hypercholesterolemia, 77% had
overweight or obesity and 10% reported history of CVD.
Those characteristics were also stratified by sex, age groups
and education level.
Alcohol consumption epidemiology
A positive linear association was observed between average
volume per day alcohol consumption and HDL-c means
levels: abstainers: 46.2 mg%; DI: 46.9 mg%; DII: 53.6 mg%
and DIII: 50.7 mg% (P: 0.0005).
Regarding patterns of drinking, the majority of the studied
population reported not to be currently drinking (37.2%
never drank and 18.3% reported to be former drinker).
Among current drinkers, moderate drinking was the most
frequent pattern (24.2%) followed by light (11.8%), binge
(5.6%) and heavy drinking (2.9%). Moderate alcohol con-
sumption was the most frequent pattern of alcohol drinking
among men, while among women never drinkers represented
the highest prevalence across all age groups (Tables 2 and 3).
Among men, the prevalence of heavy drinking was 3.9% and
the prevalence of binge drinking was 9.9%. These preva-
lences were lower in women, 2% and 1.7%, respectively.
Tables 2 and 3 also include analyses by average of pure
alcohol consumed. Most of the current drinker population
was type I drinker (42.6%). This observation was consistent
by sex and by the rest of the analyzed subgroups. Globally,
the prevalence of type II and type III drinkers were 1.2%
and 0.7% respectively. By sex, those levels of alcohol con-
sumption were higher in men than in women.
The type of beverage most frequently reported by drin-
kers was wine (51.7%) followed by beer (34.7%) and spirits
(19.7%). Wine consumption prevalence was higher in older
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age groups while beer consumption was more frequently
reported at younger age groups.
Alcohol consumption, cardiovascular risk factors
and cardiovascular risk
Compared to never smokers, current smokers showed high-
er rates of heavy and binge drinking in both sexes (Tables 2
and 3). Among women, light and moderate patterns of alco-
hol consumption were higher among non-hypertensive parti-
cipants than in hypertensive ones. Also, moderate pattern
was more frequent among non-diabetics than in diabetics.
Among men, heavy drinking was more frequent among peo-
ple with hypertension than without hypertension. Similar
patterns of consumption were observed in both sexes by
hypercholesterolemia condition.
Table 4 shows results of three different multiple logistic
regression models depicting the association between patterns
of alcohol drinking and diabetes, hypertension, dyslipidemia,
increased cardiovascular risk and CVD history. Individual
models were performed for each analysis and in all of them
the reference category was selected to be the ‘never drin-
kers’. The odds for hypertension condition were significantly
higher for men whose alcohol consumption pattern was
higher than light, whereas for women the odds were ~25%
lower for light and moderate alcohol consumption drinkers.
For women, the odds of having >20% CVD risk were
~40% lower than that of never drinkers for those with light
and moderate consumption. The odds of having a history of
CVD was ~50% lower than those with a moderate con-
sumption. For men, the odds of having >20% CVD risk
was about twice as high than in never drinkers, in those with
a heavy consumption.
Discussion
Main findings of this study
Most of the cohort participants were not current drinkers
and, among drinkers, moderate consumption was the most
frequent pattern. Heavy and binge drinking were signifi-
cantly higher among men and it is worrying that almost 14%
of men reported one of those harmful patterns of alcohol
consumption. Consistent with ENPRECOSP national sur-
vey in Argentina,23 wine is the most selected beverage and
this is especially more significant as age increases.
This study also analyzed the relation between different
patterns of alcohol consumption and different CVD risk sta-
tus as diabetes, hypertension, dislipemia, >20% CVD risk
and history of CVD. Among women, an apparently protect-
ive association was found between light and moderate alco-
hol consumption and >20% CVD risk and also between
moderate consumption and CVD history. Although
Table 1 General characteristics of the study population in the Southern Cone of Latin Americaa
n Current cigarette
smoking





Overall 7524 29.7 (28.4, 31.0) 40.8 (39.4, 42.1) 12.4 (11.5, 13.3) 58.4 (57.0, 59.8) 77.0 (75.8, 78.1) 10.0 (9.2, 10.7)
Sex
Men 3165 33.3 (31.3, 35.3) 44.7 (42.6, 46.7) 10.6 (9.4, 11.7) 68.3 (66.3, 70.2) 79.5 (77.9, 81.2) 10.4 (9.3, 11.5)
Women 4359 26.5 (24.8, 28.3) 37.3 (35.5, 39.0) 14.0 (12.8, 15.3) 49.6 (47.7, 51.5) 74.6 (73.0, 76.3) 9.6 (8.5, 10.6)
Age groups (years)
35–44 1716 33.9 (31.2, 36.5) 22.5 (20.2, 24.8) 6.1 (4.7, 7.4) 52.6 (49.8, 55.4) 73.6 (71.3, 76.0) 5.2 (4.0, 6.4)
45–54 2072 35.8 (33.4, 38.1) 38.8 (36.4, 41.2) 11.1 (9.5, 12.7) 59.6 (57.1, 62.0) 77.5 (75.4, 79.5) 8.1 (6.8, 9.4)
55–64 2114 24.2 (22.2, 26.3) 57.2 (54.8, 59.6) 18.4 (16.5, 20.3) 64.4 (62.0, 66.7) 80.5 (78.6, 82.4) 14.1 (12.4, 15.8)
65–74 1622 12.6 (10.9, 14.4) 72.4 (69.9, 74.8) 24.1 (21.7, 26.4) 63.2 (60.6, 65.8) 79.9 (77.7, 82.1) 21.5 (19.3, 23.7)
Education level
Primary school 3409 26.4 (24.5, 28.2) 50.6 (48.5, 52.6) 15.6 (14.1, 17.0) 59.3 (57.3, 61.3) 79.3 (77.6, 80.9) 13.2 (11.9, 14.5)
Secondary school 2790 31.2 (29.1, 33.3) 38.3 (36.1, 40.4) 11.7 (10.3, 13.0) 59.0 (56.8, 61.2) 78.0 (76.2, 79.8) 9.4 (8.2, 10.6)
University 1318 32.0 (28.9, 35.0) 31.1 (28.3, 33.9) 9.1 (7.3, 10.9) 56.1 (52.8, 59.3) 71.9 (69.0, 74.7) 6.3 (5.0, 7.7)
aValues are expressed as percentages (95% confidence interval). Hypertension: systolic blood pressure ≥140mmHg and/or diastolic blood pressure ≥90
mmHg and/or use of antihypertensive medication; diabetes: fasting glucose ≥126mg/dl or self-reported history of diabetes; dyslipidemia: total cholesterol
≥240mg/dl and/or LDL-cholesterol ≥160mg/dl and/or HDL-cholesterol <40 mg/dl and/or triglyceride ≥200mg/dl and/or use of lipid-lowering medication;
overweight or obesity: body mass index ≥25 kg/m2; history of cardiovascular disease: self-reported history of heart attack or angina or revascularization or
total stroke or transient ischemic attack or heart failure.
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Table 2 Estimated prevalence and 95% CI of drinking patterns among men in the study population of the Southern Cone of Latin America in 2011–12
Patterns of alcohol drinkinga Categories of average volume per day of drinking alcoholb Type of beverage
Never Former Light Moderate Heavy Binge Abstainers Drinker I Drinker II Drinker III Wine Beer Spirits
Overall 37.2 (35.8, 38.5) 18.3 (17.2, 19.3) 11.8 (10.9, 12.7) 24.2 (23.0, 25.4) 2.9 (2.5, 3.3) 5.6 (4.9, 6.3) 55.5 (54.1, 56.9) 42.6 (41.2, 44.0) 1.2 (0.9, 1.5) 0.7 (0.5, 0.9) 51.7 (49.6, 53.8) 34.7 (32.6, 36.8) 19.7 (17.9, 21.5)
Men 24.4 (22.6, 26.2) 16.8 (15.2, 18.3) 11.5 (10.1, 12.8) 33.5 (31.5, 35.4) 3.9 (3.2, 4.6) 9.9 (8.6, 11.3) 41.2 (39.2, 43.3) 55.6 (53.6, 57.7) 1.8 (1.3, 2.4) 1.3 (0.8, 1.8) 59.1 (56.4, 61.8) 40.6 (37.9, 43.4) 21.4 (19.1, 23.7)
Age groups (years)
35–44 27.2 (23.6, 30.8) 13.1 (10.3, 15.8) 12.2 (9.6, 14.9) 32.3 (28.6, 36.0) 2.5 (1.3, 3.7) 12.6 (9.8, 15.5) 40.3 (36.3, 44.3) 57.1 (53.1, 61.1) 1.4 (0.5, 2.3) 1.2 (0.3, 2.2) 52.6 (47.4, 57.8) 51.5 (46.3, 56.7) 22.6 (18.0, 27.1)
45–54 23.2 (20.0, 26.3) 16.2 (13.5, 19.0) 11.5 (9.1, 13.9) 34.3 (30.8, 37.8) 3.7 (2.4, 5.0) 11.1 (8.7, 13.5) 39.4 (35.8, 43.1) 57.2 (53.5, 60.9) 2.1 (1.1, 3.2) 1.2 (0.4, 2.0) 58.4 (53.7, 63.1) 40.9 (36.2, 45.6) 22.6 (18.5, 26.6)
55–64 20.9 (18.0, 23.7) 20.9 (18.0, 23.8) 11.6 (9.3, 14.0) 34.3 (31.0, 37.6) 5.8 (4.3, 7.4) 6.4 (4.7, 8.1) 41.8 (38.4, 45.3) 54.7 (51.2, 58.2) 2.2 (1.2, 3.1) 1.3 (0.5, 2.1) 64.3 (59.9, 68.7) 29.9 (25.6, 34.1) 18.3 (14.8, 21.9)
65–74 24.6 (21.1, 28.0) 22.9 (19.5, 26.3) 8.8 (6.4, 11.2) 33.8 (30.0, 37.6) 5.3 (3.5, 7.0) 4.5 (2.8, 6.1) 47.7 (43.6, 51.7) 48.7 (44.6, 52.7) 1.9 (0.8, 3.0) 1.8 (0.8, 2.7) 75.5 (70.7, 80.3) 20.0 (15.6, 24.4) 19.7 (15.4, 24.0)
Education level
Primary school 22.2 (19.6, 24.7) 17.9 (15.5, 20.2) 11.9 (9.8, 14.0) 31.8 (29.0, 34.7) 5.0 (3.6, 6.3) 11.2 (8.9, 13.5) 40.1 (37.0, 43.1) 56.0 (52.9, 59.1) 2.5 (1.4, 3.5) 1.4 (0.6, 2.2) 57.2 (53.0, 61.3) 38.4 (34.2, 42.6) 13.6 (10.8, 16.3)
Secondary school 24.8 (21.9, 27.6) 17.6 (15.1, 20.1) 11.3 (9.2, 13.4) 33.1 (30.0, 36.2) 3.4 (2.4, 4.4) 9.8 (7.6, 11.9) 42.4 (39.2, 45.7) 54.9 (51.6, 58.1) 1.5 (0.8, 2.2) 1.2 (0.5, 2.0) 59.0 (54.6, 63.3) 41.7 (37.3, 46.1) 23.5 (19.7, 27.3)
University 26.9 (22.6, 31.1) 13.7 (10.6, 16.8) 11.3 (8.2, 14.4) 36.2 (31.8, 40.7) 3.2 (1.9, 4.5) 8.5 (5.8, 11.3) 40.7 (36.0, 45.3) 56.5 (51.8, 61.2) 1.5 (0.6, 2.5) 1.3 (0.3, 2.3) 61.9 (56.0, 67.8) 41.9 (36.0, 47.9) 28.4 (22.9, 33.9)
Tobacco status
Never smokers 35.1 (31.7, 38.5) 15.7 (13.1, 18.2) 10.1 (7.8, 12.4) 31.2 (28.1, 34.4) 1.7 (0.8, 2.5) 6.2 (4.4, 8.0) 50.8 (47.3, 54.4) 47.7 (44.2, 51.3) 1.0 (0.4, 1.6) 0.4 (0.1, 0.7) 58.3 (53.4, 63.3) 37.2 (32.4, 42.0) 16.9 (13.2, 20.6)
Former smokers 19.1 (16.3, 21.9) 22.2 (19.3, 25.1) 12.5 (10.2, 14.8) 33.6 (30.3, 36.9) 4.6 (3.3, 5.9) 8.0 (5.9, 10.1) 41.3 (37.8, 44.8) 55. 9 (52.4, 59.4) 1.7 (0.8, 2.5) 1.1 (0.5, 1.7) 61.0 (56.4, 65.5) 39.5 (34.8, 44.2) 19.6 (15.8, 23.4)
Current cigarettes
smokers
18.2 (15.3, 21.1) 12.8 (10.4, 15.2) 12.0 (9.6, 14.5) 35.7 (32.1, 39.3) 5.5 (4.0, 7.0) 15.8 (12.8, 18.7) 31.0 (27.6, 34.4) 63.7 (60.1, 67.3) 2.8 (1.7, 4.0) 2.5 (1.2, 3.7) 58.2 (53.7, 62.7) 44.2 (39.6, 48.8) 26.3 (22.1, 30.4)
Hypertension
No 26.7 (24.1, 29.4) 16.0 (13.9, 18.1) 11.8 (9.9, 13.7) 32.7 (30.0, 35.4) 2.7 (1.9, 3.5) 10.0 (8.0, 11.9) 42.8 (39.8, 45.7) 54.6 (51.7, 57.6) 1.4 (0.7, 2.0) 1.3 (0.5, 2.0) 57.5 (53.7, 61.4) 44.0 (40.1, 47.9) 24.6 (21.1, 28.1)
Yes 21.5 (19.1, 23.8) 17.7 (15.5, 19.9) 11.1 (9.2, 13.0) 34.4 (31.7, 37.2) 5.3 (4.1, 6.5) 9.9 (8.0, 11.8) 39.2 (36.4, 42.1) 57.0 (54.1, 59.8) 2.4 (1.6, 3.2) 1.4 (0.8, 1.9) 60.9 (57.2, 64.7) 36.7 (33.0, 40.4) 17.7 (14.7, 20.6)
Diabetes
No 24.8 (22.8, 26.8) 15.9 (14.3, 17.5) 11.4 (9.9, 12.8) 34.0 (31.9, 36.1) 3.8 (3.0, 4.5) 10.1 (8.6, 11.6) 40.8 (38.6, 43.0) 56.1 (53.8, 58.3) 1.8 (1.3, 2.4) 1.3 (0.8, 1.9) 58.9 (56.0, 61.8) 41.7 (38.8, 44.6) 22.2 (19.7, 24.8)
Yes 23.1 (18.3, 27.9) 23.5 (18.8, 28.1) 12.2 (8.3, 16.2) 30.0 (24.8, 35.2) 3.4 (1.6, 5.2) 7.7 (4.3, 11.2) 46.6 (40.9, 52.3) 51.0 (45.4, 56.7) 1.4 (0.3, 2.5) 0.9 (0.1, 1.8) 61.9 (54.0, 69.8) 31.3 (23.5, 39.1) 15.0 (9.5, 20.6)
Dyslipidemia
No 23.3 (20.0, 26.5) 16.1 (13.4, 18.8) 9.5 (7.4, 11.6) 35.4 (31.9, 38.9) 4.8 (3.4, 6.2) 10.8 (8.3, 13.3) 39.5 (35.8, 43.1) 56.4 (52.7, 60.1) 2.7 (1.6, 3.9) 1.4 (0.5, 2.3) 62.7 (58.1, 67.3) 41.5 (36.8, 46.2) 18.6 (14.9, 22.3)
Yes 25.2 (23.0, 27.5) 17.0 (15.1, 18.8) 12.4 (10.6, 14.1) 32.7 (30.4, 35.1) 3.2 (2.4, 4.0) 9.4 (7.8, 11.1) 42.3 (39.7, 44.8) 55.2 (52.6, 57.7) 1.4 (0.8, 1.9) 1.2 (0.7, 1.8) 57.4 (54.0, 60.8) 40.4 (37.0, 43.8) 22.9 (19.9, 25.9)
Framingham risk
Low 28.3 (24.8, 31.9) 14.0 (11.3, 16.8) 11.9 (9.4, 14.3) 33.1 (29.5, 36.7) 2.3 (1.2, 3.4) 10.3 (7.8, 12.8) 42.4 (38.6, 46.3) 55.5 (51.6, 59.4) 1.5 (0.6, 2.4) 0.6 (−0.0, 1.2) 51.7 (46.6, 56.7) 49.9 (44.8, 54.9) 20.9 (16.6, 25.1)
Med 22.1 (18.8, 25.5) 16.5 (13.6, 19.4) 11.0 (8.4, 13.7) 34.2 (30.4, 38.0) 3.8 (2.4, 5.2) 12.2 (9.3, 15.2) 38.7 (34.8, 42.6) 58.0 (54.0, 62.0) 1.9 (0.9, 2.9) 1.5 (0.4, 2.5) 62.8 (57.7, 68.0) 40.8 (35.5, 46.1) 24.5 (19.7, 29.3)
High 22.1 (19.2, 24.9) 17.6 (15.1, 20.2) 12.8 (10.4, 15.3) 34.4 (31.2, 37.7) 5.4 (4.0, 6.8) 7.5 (5.6, 9.4) 39.8 (36.5, 43.1) 56.9 (53.5, 60.3) 1.8 (1.0, 2.7) 1.5 (0.8, 2.2) 63.6 (59.2, 67.9) 29.9 (25.7, 34.0) 19.8 (16.2, 23.3)
History of CVD
No 24.6 (22.7, 26.6) 15.8 (14.2, 17.4) 11.9 (10.4, 13.4) 33.7 (31.6, 35.8) 3.7 (3.0, 4.5) 10.2 (8.7, 11.6) 40.5 (38.3, 42.7) 56.7 (54.5, 58.9) 1.7 (1.2, 2.2) 1.1 (0.7, 1.6) 58.3 (55.5, 61.2) 41.4 (38.5, 44.3) 21.7 (19.3, 24.2)




38.1 (34.3, 41.9) 10.1 (7.9, 12.2) 0.8 (0.0, 1.5) 41.5 (37.6, 45.3) 1.7 (0.7, 2.7) 8.0 (5.7, 10.2) 48.1 (44.2, 52.0) 51.2 (47.3, 55.1) 0.6 (0.1, 1.1) 0.1 (−0.1, 0.2) 83.8 (79.6, 88.0) 37.6 (32.2, 43.0) 6.4 (3.6, 9.2)
Bariloche,
Argentina
21.1 (18.0, 24.2) 13.0 (10.5, 15.4) 18.9 (15.9, 21.8) 33.6 (30.0, 37.1) 7.1 (5.2, 8.9) 6.2 (4.3, 8.1) 34.2 (30.7, 37.8) 61.2 (57.5, 64.8) 3.2 (1.9, 4.5) 1.4 (0.6, 2.2) 52.5 (48.0, 57.1) 31.3 (26.9, 35.6) 5.2 (3.1, 7.2)
Continued
decreased risk for cardiovascular outcomes and moderate
alcohol consumption has also been described for men,6,9 we
did not find that association. Harmful association was
observed between heavy drinking and >20% CVD risk for
men. Hypertension status was strongly associated with alco-
hol consumption among men with a pattern higher than
light, while a protective association was observed for women
that reported light and moderate levels. This last finding
could be associated with the lower CVD risk observed in
these levels of consumption among women.
What is already known on this topic
These observations are also in line with figure analyses done
from the Euromonitor database showing that in these coun-
tries mean annual growth in sales decreased for wine and
increased for beer in the last 15 years. However, 50.6% of
the market share in Argentina still goes to wine and 33.2%
to beer (N. Espínola, personal communication, 18 April
2018). IHME GBD estimations for 2016 show that the
DALY rates for some alcohol-attributable conditions, such
as alcohol use disorders are higher for Chile than for
Argentina or Uruguay.2
In relation to the observations on the association between
heavy drinking and CVD risk, a meta-analysis of association
of alcohol consumption with selected CVD outcomes has
found that the lower risk of coronary heart disease asso-
ciated with 2.5–14.9 g/day of alcohol consumption was
stronger for women than for men.10 At the INTERHEART
study, a case–control study performed in 52 different coun-
tries, a protected relationship between regular alcohol con-
sumption and myocardial infarction32 was observed and in
this case, an apparently greater protective association in
women than in men was also observed.33 However, and very
importantly, the protective relation with alcohol consumption
was not present in the sub analysis for Latin American coun-
tries that participated in at the INTERHEART study, includ-
ing wine-producing countries such as Argentina and Chile.34
As discussed in that study, different patterns of alcohol con-
sumption or type of alcohol consumed may play a role on
risk. In Chile, for example, it has been described that alcohol
consumption per capita is even higher than that of some
European alcoholic beverage-producing countries such as
France.35,36
Multiple published data has widely supported the associ-
ation between excessive alcohol intake and the development
of hypertension37–39; this is clearly correlated in our data for
men. However, an apparently protective association of light
and moderate consumption among women was observed
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Table 3 Estimated prevalence and 95% CI of drinking patterns among women in the study population of the Southern Cone of Latin America in 2011–12
Patterns of alcohol drinkinga Categories of average volume per day of drinking alcoholb Type of beverage
Never Former Light Moderate Heavy Binge Abstainers Drinker I Drinker II Drinker III Wine Beer Spirits
Overall 37.2 (35.8, 38.5) 18.3 (17.2, 19.3) 11.8 (10.9, 12.7) 24.2 (23.0, 25.4) 2.9 (2.5, 3.3) 5.6 (4.9, 6.3) 55.5 (54.1, 56.9) 42.6 (41.2, 44.0) 1.2 (0.9, 1.5) 0.7 (0.5, 0.9) 51.7 (49.6, 53.8) 34.7 (32.6, 36.8) 19.7 (17.9, 21.5)
Women 48.6 (46.7, 50.4) 19.6 (18.1, 21.1) 12.1 (10.8, 13.3) 16.0 (14.6, 17.4) 2.0 (1.5, 2.5) 1.7 (1.2, 2.2) 68.2 (66.4, 70.0) 31.0 (29.2, 32.7) 0.7 (0.4, 0.9) 0.2 (0.1, 0.3) 39.5 (36.2, 42.7) 25.0 (22.0, 28.0) 16.8 (14.0, 19.6)
Age groups (years)
35–44 44.3 (40.6, 48.0) 18.3 (15.4, 21.3) 14.2 (11.6, 16.9) 18.4 (15.4, 21.4) 2.0 (1.0, 3.0) 2.7 (1.5, 3.8) 62.7 (59.0, 66.3) 36.7 (33.1, 40.4) 0.5 (0.1, 0.9) 0.1 (0.0, 0.3) 33.1 (27.3, 38.9) 30.6 (24.9, 36.2) 21.1 (15.8, 26.4)
45–54 48.2 (44.9, 51.5) 19.3 (16.7, 22.0) 11.9 (9.8, 14.0) 17.2 (14.8, 19.7) 2.0 (1.2, 2.8) 1.4 (0.6, 2.1) 67.5 (64.5, 70.6) 31.7 (28.6, 34.7) 0.6 (0.2, 1.0) 0.2 (0.0, 0.5) 39.5 (34.0, 44.9) 28.1 (22.9, 33.2) 16.1 (11.5, 20.8)
55–64 52.9 (49.6, 56.3) 20.9 (18.1, 23.7) 11.4 (9.4, 13.5) 11.7 (9.7, 13.7) 1.9 (1.1, 2.7) 1.1 (0.4, 1.8) 73.9 (71.0, 76.7) 25.0 (22.3, 27.8) 0.8 (0.3, 1.3) 0.3 (0.0, 0.6) 44.0 (37.9, 50.0) 12.0 (8.2, 15.8) 8.7 (5.2, 12.2)




54.9 (52.2, 57.6) 20.0 (17.7, 22.2) 10.8 (9.0, 12.5) 11.4 (9.7, 13.2) 1.5 (0.9, 2.0) 1.4 (0.8, 2.1) 74.9 (72.5, 77.3) 24.2 (21.8, 26.6) 0.8 (0.4, 1.2) 0.2 (0.0, 0.3) 38.4 (33.2, 43.6) 23.4 (18.4, 28.4) 9.1 (6.0, 12.2)
Secondary
school
49.7 (46.7, 52.7) 19.7 (17.3, 22.2) 11.5 (9.7, 13.4) 15.6 (13.4, 17.8) 1.8 (1.2, 2.4) 1.6 (0.9, 2.4) 69.4 (66.7, 72.2) 29.8 (27.1, 32.6) 0.6 (0.2, 1.0) 0.1 (0.0, 0.2) 39.5 (34.3, 44.6) 25.2 (20.5, 29.9) 14.8 (10.6, 18.9)




58.5 (56.0, 61.0) 19.0 (16.9, 21.0) 10.3 (8.7, 11.9) 10.6 (9.2, 12.1) 1.2 (0.8, 1.6) 0.4 (0.1, 0.7) 77.4 (75.4, 79.5) 22.2 (20.2, 24.3) 0.3 (0.1, 0.5) 0.1 (0.0, 0.2) 40.6 (35.7, 45.5) 21.3 (17.1, 25.5) 10.3 (6.9, 13.6)
Former
smokers




34.9 (31.4, 38.5) 18.7 (15.7, 21.7) 14.9 (12.1, 17.7) 24.1 (20.6, 27.6) 3.7 (2.3, 5.0) 3.7 (2.2, 5.2) 53.6 (49.8, 57.5) 44.9 (41.1, 48.8) 1.0 (0.4, 1.6) 0.4 (0.0, 0.8) 37.4 (31.7, 43.0) 26.4 (21.1, 31.8) 25.5 (19.9, 31.1)
Hypertension
No 45.9 (43.4, 48.4) 18.2 (16.2, 20.2) 13.6 (11.9, 15.3) 18.3 (16.3, 20.3) 2.2 (1.5, 2.9) 1.7 (1.1, 2.4) 64.2 (61.7, 66.6) 35.1 (32.7, 37.5) 0.6 (0.3, 0.9) 0.1 (0.0, 0.3) 38.1 (34.0, 42.1) 25.9 (22.1, 29.7) 18.8 (15.2, 22.5)
Yes 53.0 (50.3, 55.8) 21.9 (19.6, 24.2) 9.5 (7.9, 11.2) 12.3 (10.4, 14.1) 1.7 (1.1, 2.3) 1.5 (0.8, 2.3) 75.0 (72.6, 77.4) 24.1 (21.7, 26.4) 0.7 (0.3, 1.1) 0.2 (0.0, 0.5) 42.9 (37.5, 48.2) 22.9 (18.1, 27.6) 11.9 (8.0, 15.9)
Diabetes
No 47.6 (45.6, 49.7) 19.4 (17.7, 21.0) 12.3 (10.9, 13.6) 16.8 (15.3, 18.4) 2.2 (1.6, 2.7) 1.7 (1.1, 2.2) 67.1 (65.1, 69.0) 32.0 (30.1, 34.0) 0.7 (0.5, 1.0) 0.2 (0.0, 0.3) 39.7 (36.2, 43.2) 25.3 (22.0, 28.5) 17.4 (14.4, 20.5)
Yes 53.5 (48.7, 58.4) 21.3 (17.3, 25.4) 11.5 (8.3, 14.7) 11.2 (8.0, 14.4) 1.0 (0.1, 1.9) 1.4 (0.0, 2.7) 74.9 (70.5, 79.2) 24.6 (20.3, 28.9) 0.3 (0.0, 0.8) 0.3 (0.0, 0.8) 35.7 (26.2, 45.2) 23.4 (14.1, 32.7) 12.6 (5.3, 19.9)
Dyslipidemia
No 46.9 (44.2, 49.7) 18.2 (16.1, 20.4) 13.0 (11.1, 14.8) 17.6 (15.4, 19.7) 2.1 (1.5, 2.8) 2.1 (1.2, 3.0) 65.2 (62.6, 67.8) 33.9 (31.2, 36.5) 0.8 (0.4, 1.1) 0.2 (0.0, 0.3) 38.8 (34.3, 43.4) 24.9 (20.7, 29.0) 18.3 (14.2, 22.4)
Yes 49.9 (47.3, 52.5) 21.3 (19.1, 23.4) 11.3 (9.6, 13.0) 14.5 (12.6, 16.3) 1.9 (1.2, 2.6) 1.1 (0.6, 1.7) 71.2 (68.8, 73.6) 28.0 (25.7, 30.4) 0.6 (0.3, 0.9) 0.2 (0.0, 0.4) 40.1 (35.3, 44.8) 25.1 (20.6, 29.6) 15.3 (11.4, 19.1)
Framingham risk
Low 46.5 (44.0, 49.0) 18.2 (16.2, 20.1) 13.4 (11.7, 15.1) 18.3 (16.3, 20.3) 2.2 (1.5, 2.8) 1.5 (0.8, 2.1) 64.7 (62.3, 67.1) 34.6 (32.2, 37.0) 0.6 (0.3, 0.9) 0.1 (0.0, 0.2) 36.9 (32.9, 41.0) 26.5 (22.7, 30.3) 18.7 (15.0, 22.4)
Med 49.2 (45.2, 53.1) 20.8 (17.6, 24.0) 11.3 (8.8, 13.8) 14.6 (11.8, 17.5) 2.0 (1.0, 3.0) 2.0 (0.7, 3.3) 70.0 (66.4, 73.7) 28.5 (24.9, 32.1) 1.0 (0.3, 1.8) 0.4 (0.1, 1.0) 45.9 (38.7, 53.1) 23.4 (16.5, 30.3) 8.2 (4.1, 12.3)
High 54.8 (49.6, 59.9) 23.3 (18.8, 27.9) 8.1 (5.3, 10.8) 11.0 (7.8, 14.1) 1.1 (0.3, 1.9) 1.8 (0.2, 3.4) 78.1 (73.9, 82.3) 21.4 (17.2, 25.6) 0.5 (0.1, 1.1) 0.0 (0.0, 0.0) 53.0 (42.2, 63.9) 13.3 (5.4, 21.1) 21.4 (11.7, 31.1)
History of CVD
No 48.0 (46.0, 50.0) 19.1 (17.5, 20.7) 12.4 (11.1, 13.8) 16.9 (15.3, 18.4) 2.0 (1.5, 2.6) 1.6 (1.1, 2.1) 67.1 (65.2, 69.0) 32.1 (30.2, 34.0) 0.7 (0.4, 0.9) 0.1 (0.0, 0.3) 39.5 (36.1, 42.9) 25.2 (22.0, 28.4) 17.0 (14.0, 19.9)
Yes 54.1 (48.6, 59.5) 24.9 (20.1, 29.6) 8.9 (6.0, 11.8) 8.2 (5.3, 11.1) 1.8 (0.7, 2.9) 2.1 (0.4, 3.8) 79.0 (74.7, 83.2) 20.1 (15.9, 24.3) 0.5 (0.1, 1.1) 0.5 (0.1, 1.0) 39.3 (28.3, 50.3) 22.1 (12.4, 31.8) 14.5 (6.9, 22.2)
City















































moderate alcohol consumption and risk of hypertension in
>70 000 women showed a J-shaped curve for the associ-
ation.40 However, findings of studies in this field show dis-
crepant results with no strong conclusion on prospective
effect of light and moderate consumption patterns and risk
of hypertension.37,41
In relation to gender differences, acute differences in
moderate drinking effects have been associated with gender
differences in alcohol pharmacokinetics (absorption, distri-
bution and elimination).42 However, additional studies might
shed further light on the effects of those biological differ-
ences in long-term effects by gender. In this sense, a recent
systematic analysis for the Global Burden Disease Study
2016, reported that alcohol use caused far more health loss
among men than women.43 Among the strengths of these
results, it is important to highlight that in all performed ana-
lyses never drinkers were used as reference, which is very
important as the inclusion of former drinkers in the refer-
ence group of abstainers could lead to incorrect conclusions.
What this study adds
This study provides valuable data on alcohol consumption
in a population-based sample of four mid-sized cities of the
Southern Cone of Latin America. To our knowledge, this is
the first study that describes the association of the different
patterns of alcohol consumption and cardiovascular risk on
data coming from general population in this region.
Limitations of this study
Under-reporting due to alcohol stigma or ‘willingness to please’
could result in bias for both sexes. Self-reporting of CVD cases
might not capture both ends of the severity spectrum (CVD
victims and subclinical atherosclerosis). Moreover, we evaluated
total stroke, but one of the complex associations of alcohol
consumption and CVD is the lower relative risk observed for
ischemic strokes and higher relative risk for hemorrhagic stroke
type.10 Notwithstanding the fact that estimated association
measures reported in the present study come from observa-
tional data, all this epidemiological knowledge comes from the
first population-based cohort in the southern cone of Latin
America, based on a cluster-randomized representative sam-
pling of nearly 8000 people.
Populations net effects of alcohol on cardiovascular out-
comes are significantly influenced by the type of study design
used and population characteristics. There is need of an
adequate, well-conducted experimental study design as a rando-
mized clinical trial to clarify the actual effect of consumption of
alcohol on cardiovascular health. General recommendations to
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Conclusions
In this representative population-based sample of the
Southern Cone of Latin America, the majority of the partici-
pants reported to be current non-drinkers and, among drin-
kers, moderate alcohol consumption was the most frequent
pattern observed.
For women, the odds of having >20% CVD risk were lower
for those with light and moderate consumption than that of
never drinkers. For history of CVD, the odds were also lower
in those with a moderate consumption. For men, the odds of
having >20% CVD risk were about twice as high among those
with a heavy consumption than in never drinkers.
Supplementary data
Supplementary data are available at the Journal of Public
Health online.
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